BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 15978095)

  • 21. FK419, a nonpeptide platelet glycoprotein IIb/IIIa antagonist, ameliorates brain infarction associated with thrombotic focal cerebral ischemia in monkeys: comparison with tissue plasminogen activator.
    Maeda M; Moriguchi A; Mihara K; Aoki T; Takamatsu H; Matsuoka N; Mutoh S; Goto T
    J Cereb Blood Flow Metab; 2005 Jan; 25(1):108-18. PubMed ID: 15678117
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of CD147 (Cluster of Differentiation 147) Ameliorates Acute Ischemic Stroke in Mice by Reducing Thromboinflammation.
    Jin R; Xiao AY; Chen R; Granger DN; Li G
    Stroke; 2017 Dec; 48(12):3356-3365. PubMed ID: 29114092
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Focal Ischemic Injury with Complex Middle Cerebral Artery in Stroke-Prone Spontaneously Hypertensive Rats with Loss-Of-Function in NADPH Oxidases.
    Yao H; Ferdaus MZ; Zahid HM; Ohara H; Nakahara T; Nabika T
    PLoS One; 2015; 10(9):e0138551. PubMed ID: 26389812
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chronic nicotine treatment enhances focal ischemic brain injury and depletes free pool of brain microvascular tissue plasminogen activator in rats.
    Wang L; Kittaka M; Sun N; Schreiber SS; Zlokovic BV
    J Cereb Blood Flow Metab; 1997 Feb; 17(2):136-46. PubMed ID: 9040492
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Phosphorylated recombinant HSP27 protects the brain and attenuates blood-brain barrier disruption following stroke in mice receiving intravenous tissue-plasminogen activator.
    Shimada Y; Shimura H; Tanaka R; Yamashiro K; Koike M; Uchiyama Y; Urabe T; Hattori N
    PLoS One; 2018; 13(5):e0198039. PubMed ID: 29795667
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Encapsulation of tissue plasminogen activator in pH-sensitive self-assembled antioxidant nanoparticles for ischemic stroke treatment - Synergistic effect of thrombolysis and antioxidant.
    Mei T; Kim A; Vong LB; Marushima A; Puentes S; Matsumaru Y; Matsumura A; Nagasaki Y
    Biomaterials; 2019 Sep; 215():119209. PubMed ID: 31181394
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Compartmentalized Actions of the Plasminogen Activator Inhibitors, PAI-1 and Nsp, in Ischemic Stroke.
    Torrente D; Su EJ; Fredriksson L; Warnock M; Bushart D; Mann KM; Emal CD; Lawrence DA
    Transl Stroke Res; 2022 Oct; 13(5):801-815. PubMed ID: 35122213
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tissue plasminogen activator and plasminogen activator inhibitor in patients with acute ischemic stroke: relation to stroke etiology.
    Zunker P; Schick A; PadrĂ³ T; Kienast J; Phillips A; Ringelstein EB
    Neurol Res; 1999 Dec; 21(8):727-32. PubMed ID: 10596380
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intra-artery infusion of recombinant human erythropoietin reduces blood-brain barrier disruption in rats following cerebral ischemia and reperfusion.
    Wang R; Wu X; Liang J; Qi Z; Liu X; Min L; Ji X; Luo Y; Zhao H
    Int J Neurosci; 2015; 125(9):693-702. PubMed ID: 25226558
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Thrombin mutant W215A/E217A treatment improves neurological outcome and reduces cerebral infarct size in a mouse model of ischemic stroke.
    Berny-Lang MA; Hurst S; Tucker EI; Pelc LA; Wang RK; Hurn PD; Di Cera E; McCarty OJ; Gruber A
    Stroke; 2011 Jun; 42(6):1736-41. PubMed ID: 21512172
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Combination of tissue-plasminogen activator with erythropoietin induces blood-brain barrier permeability, extracellular matrix disaggregation, and DNA fragmentation after focal cerebral ischemia in mice.
    Zechariah A; ElAli A; Hermann DM
    Stroke; 2010 May; 41(5):1008-12. PubMed ID: 20360548
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lysophosphatidic acid increased infarct size in the early stage of cerebral ischemia-reperfusion with increased BBB permeability.
    Chi OZ; Mellender SJ; Kiss GK; Chiricolo A; Liu X; Patel N; Jacinto E; Weiss HR
    J Stroke Cerebrovasc Dis; 2020 Oct; 29(10):105029. PubMed ID: 32912542
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anesthesia-Induced Hypothermia Attenuates Early-Phase Blood-Brain Barrier Disruption but Not Infarct Volume following Cerebral Ischemia.
    Liu YC; Lee YD; Wang HL; Liao KH; Chen KB; Poon KS; Pan YL; Lai TW
    PLoS One; 2017; 12(1):e0170682. PubMed ID: 28118390
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hyperbaric oxygen reduces blood-brain barrier damage and edema after transient focal cerebral ischemia.
    Veltkamp R; Siebing DA; Sun L; Heiland S; Bieber K; Marti HH; Nagel S; Schwab S; Schwaninger M
    Stroke; 2005 Aug; 36(8):1679-83. PubMed ID: 16020761
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recombinant tissue-type plasminogen activator transiently enhances blood-brain barrier permeability during cerebral ischemia through vascular endothelial growth factor-mediated endothelial endocytosis in mice.
    Suzuki Y; Nagai N; Yamakawa K; Muranaka Y; Hokamura K; Umemura K
    J Cereb Blood Flow Metab; 2015 Dec; 35(12):2021-31. PubMed ID: 26219596
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Temporary and permanent focal cerebral ischemia in the mouse: assessment of cerebral blood flow, brain damage and blood-brain barrier permeability.
    Mao Y; Yang G; Zhou L
    Chin Med J (Engl); 2000 Apr; 113(4):361-6. PubMed ID: 11775237
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Folate deficiency increases postischemic brain injury.
    Endres M; Ahmadi M; Kruman I; Biniszkiewicz D; Meisel A; Gertz K
    Stroke; 2005 Feb; 36(2):321-5. PubMed ID: 15625295
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neointima formation and thrombosis after vascular injury in transgenic mice overexpressing plasminogen activator inhibitor-1 (PAI-1).
    Lijnen HR; Van Hoef B; Umans K; Collen D
    J Thromb Haemost; 2004 Jan; 2(1):16-22. PubMed ID: 14717961
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differential role of components of the fibrinolytic system in the formation and removal of thrombus induced by endothelial injury.
    Matsuno H; Kozawa O; Niwa M; Ueshima S; Matsuo O; Collen D; Uematsu T
    Thromb Haemost; 1999 Apr; 81(4):601-4. PubMed ID: 10235447
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Combined therapy with PJ34, a poly(ADP-ribose)polymerase inhibitor, reduces tissue plasminogen activator-induced hemorrhagic transformations in cerebral ischemia in mice.
    Haddad M; Beray-Berthat V; Coqueran B; Plotkine M; Marchand-Leroux C; Margaill I
    Fundam Clin Pharmacol; 2013 Aug; 27(4):393-401. PubMed ID: 22436003
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.